Ballentine Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$688K Buy
5,475
+1,651
+43% +$207K 0.01% 395
2025
Q1
$523K Buy
3,824
+1,384
+57% +$189K 0.01% 434
2024
Q4
$373K Buy
2,440
+911
+60% +$139K 0.01% 510
2024
Q3
$296K Sell
1,529
-1,805
-54% -$350K 0.01% 596
2024
Q2
$773K Buy
3,334
+1,667
+100% +$386K 0.01% 317
2024
Q1
$359K Buy
1,667
+18
+1% +$3.88K 0.01% 487
2023
Q4
$427K Buy
1,649
+121
+8% +$31.3K 0.01% 405
2023
Q3
$393K Buy
1,528
+48
+3% +$12.3K 0.01% 367
2023
Q2
$422K Buy
1,480
+59
+4% +$16.8K 0.01% 356
2023
Q1
$395K Sell
1,421
-60
-4% -$16.7K 0.01% 349
2022
Q4
$410K Sell
1,481
-1
-0.1% -$277 0.01% 316
2022
Q3
$395K Buy
1,482
+307
+26% +$81.8K 0.01% 282
2022
Q2
$241K Sell
1,175
-71
-6% -$14.6K 0.01% 364
2022
Q1
$263K Sell
1,246
-77
-6% -$16.3K 0.01% 380
2021
Q4
$317K Buy
1,323
+172
+15% +$41.2K 0.01% 356
2021
Q3
$326K Sell
1,151
-162
-12% -$45.9K 0.01% 311
2021
Q2
$454K Sell
1,313
-97
-7% -$33.5K 0.02% 249
2021
Q1
$395K Sell
1,410
-39
-3% -$10.9K 0.01% 256
2020
Q4
$355K Sell
1,449
-3,835
-73% -$940K 0.01% 253
2020
Q3
$1.5M Sell
5,284
-1,651
-24% -$469K 0.07% 101
2020
Q2
$1.86M Sell
6,935
-54
-0.8% -$14.4K 0.09% 90
2020
Q1
$2.21M Buy
6,989
+58
+0.8% +$18.3K 0.13% 70
2019
Q4
$2.06M Buy
6,931
+4,918
+244% +$1.46M 0.09% 88
2019
Q3
$468K Buy
2,013
+48
+2% +$11.2K 0.02% 214
2019
Q2
$460K Buy
1,965
+23
+1% +$5.38K 0.02% 222
2019
Q1
$459K Sell
1,942
-7
-0.4% -$1.65K 0.02% 198
2018
Q4
$587K Sell
1,949
-278
-12% -$83.7K 0.03% 176
2018
Q3
$787K Sell
2,227
-1,877
-46% -$663K 0.04% 152
2018
Q2
$1.19M Buy
4,104
+56
+1% +$16.3K 0.07% 94
2018
Q1
$1.11M Buy
4,048
+2,171
+116% +$595K 0.06% 96
2017
Q4
$598K Buy
1,877
+202
+12% +$64.4K 0.03% 169
2017
Q3
$525K Sell
1,675
-20
-1% -$6.27K 0.03% 187
2017
Q2
$480K Buy
1,695
+368
+28% +$104K 0.04% 201
2017
Q1
$364K Sell
1,327
-446
-25% -$122K 0.03% 158
2016
Q4
$495K Sell
1,773
-139
-7% -$38.8K 0.04% 115
2016
Q3
$599K Sell
1,912
-53
-3% -$16.6K 0.05% 83
2016
Q2
$476K Buy
1,965
+154
+9% +$37.3K 0.04% 116
2016
Q1
$472K Buy
1,811
+507
+39% +$132K 0.04% 113
2015
Q4
$400K Sell
1,304
-105
-7% -$32.2K 0.04% 111
2015
Q3
$412K Buy
1,409
+208
+17% +$60.8K 0.04% 101
2015
Q2
$485K Buy
1,201
+44
+4% +$17.8K 0.05% 92
2015
Q1
$488K Sell
1,157
-10
-0.9% -$4.22K 0.05% 89
2014
Q4
$396K Sell
1,167
-131
-10% -$44.5K 0.05% 107
2014
Q3
$429K Buy
1,298
+111
+9% +$36.7K 0.05% 93
2014
Q2
$374K Sell
1,187
-39
-3% -$12.3K 0.04% 99
2014
Q1
$375K Buy
1,226
+56
+5% +$17.1K 0.04% 98
2013
Q4
$327K Buy
1,170
+80
+7% +$22.4K 0.04% 111
2013
Q3
$262K Buy
+1,090
New +$262K 0.03% 118